Skip to main content
Equibles

XTX Topco Ltd

Position in FATE — Fate Therapeutics Inc

CIK 1828301 LONDON, X0
Back to FATE Full portfolio

Position in FATE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$488,230
+$21,228 QoQ
Shares Held
180,826
-53.5% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#43
of 156 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $414,894,447 across 381 Biotechnology names. FATE ranks #180 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 30,522 $19,031,687
2 ASND
Ascendis Pharma A/S
 43,289 $11,546,042
3 BBIO
BridgeBio Pharma, Inc.
 116,611 $8,685,187
4 MRNA
Moderna, Inc.
 123,281 $8,633,368
5 JAZZ
Jazz Pharmaceuticals plc
 30,496 $7,348,621
6 KYMR
Kymera Therapeutics, Inc.
 61,501 $7,052,319
7 CYTK
Cytokinetics Inc
 80,743 $6,878,496
8 PTCT
Ptc Therapeutics, Inc.
 81,923 $6,682,459

All Filings in FATE

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $488,230 180,826
2026-03-31 $467,002 389,169
2025-12-31 $357,443 364,738
2025-09-30 $551,776 437,918
2025-06-30 $484,207 432,328
2025-03-31 $362,853 459,308
2024-12-31 $412,170 249,800
2024-06-30 $111,185 33,898
2024-03-31 $127,627 17,388
2023-09-30 $408,990 192,920
2023-06-30 $102,811 21,599
2023-03-31 $160,683 28,190
2022-12-31 $1,051,277 104,190
2022-09-30 $459,853 20,520
2021-06-30 $437,334 5,039